A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.